Extended results of the Alzheimer's disease anti-inflammatory prevention trial. - Wikidata - wikimedia - TriplyDB

Extended results of the Alzheimer's disease anti-inflammatory prevention trial.

Extended results of the Alzheimer's disease anti-inflammatory prevention trial.

http://www.wikidata.org/entity/Q35146385

about

Targeting innate immunity for neurodegenerative disorders of the central nervous system Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ Alzheimer's Disease: Exploring the Role of Inflammation and Implications for Treatment Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer's Disease Non-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?Alzheimer's disease and periodontitis--an elusive link The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?The airbag problem-a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer's disease Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy M1 and M2 immune activation in Parkinson's Disease: Foe and ally?Targeting neuroinflammation in Alzheimer's disease Innate Immunity Fights Alzheimer's Disease APOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective Neuroinflammation in Alzheimer's disease Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice.Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.Lead optimization studies of cinnamic amide EP2 antagonists Intermittent fasting attenuates lipopolysaccharide-induced neuroinflammation and memory impairment.Prostanoid receptor EP2 as a therapeutic target Neuroinflammatory challenges compromise neuronal function in the aging brain: Postoperative cognitive delirium and Alzheimer's disease.Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative Diseases.Change in inflammatory markers and cognitive status in the oldest-old women from the Study of Osteoporotic Fractures.Effects of collagen-induced rheumatoid arthritis on amyloidosis and microvascular pathology in APP/PS1 mice.Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife.Inflammatory regulation of ATP binding cassette efflux transporter expression and function in microglia Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease.The transitioning from trials to extended follow-up studies.Nasal NSAIDs for Alzheimer's Disease.Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial Aβ42 phagocytosis.Beraprost sodium protects against chronic brain injury in aluminum-overload rats.Advances in the prevention of Alzheimer's disease and dementia TAM receptor deficiency affects adult hippocampal neurogenesis.Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging.Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology.Bridging the Translation Gap: From Dementia Risk Assessment to Advice on Risk Reduction Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer's disease.

P2860

Q26744219-3DDE1E05-939B-4A8B-8807-9CC7730E76AE Q26747585-25863EBF-6E20-4D3E-8C71-5BC0259ADF3A Q26748713-631E7991-86A7-4A33-9C58-5818ACE00A76 Q26750987-8CF8281A-E877-4CB4-A89D-C716865733F3 Q26776157-00B4BA62-7616-4163-9F83-A713C8F759E7 Q26781090-2A123294-0ADF-4123-9BC7-8C63142C2DE7 Q26783325-21D0BF6F-63A4-485A-90F4-8FC5650869F8 Q26822022-63F58512-87C3-4B47-9A2F-0822FEEA0D9E Q26827834-F3D14232-478A-4F7A-9405-89E4FC28748A Q26861263-F57093F6-23EE-4CDC-A5BB-E38EB61CE9FA Q26991654-73C649A2-CD3D-4892-9DA3-D00F83B0388C Q27014919-DDE208C5-252A-4C97-AA60-A93E57EBFA01 Q27024667-FB305B18-8158-4B18-8A70-9FA6B3DA143D Q28078474-13B7828A-A61A-4277-A65D-DEC28AFEDC8E Q28081826-EDF0E835-A71B-4922-A761-14A502AEA580 Q28085213-483BD7F1-A508-44A5-9300-CFD370C7E267 Q28259238-A3B2E8D6-20B0-45A8-85B7-B4394E785FA1 Q30527791-073D4D6A-B8C1-4C19-ACDB-24DDB52F0BC8 Q33624653-36213ABA-0C59-49C1-A54C-878166F28818 Q33654575-281A6AFA-3821-45C4-9DAA-D291461E01CD Q33696681-7603C60A-434D-4197-830C-16DD32674585 Q33711678-CE771E98-09CF-44DC-AB47-520F7AD7CFB3 Q33745149-4425E1FD-74C1-4311-AAC6-11D167E07557 Q33745617-0E180AB1-9285-4728-937F-E93D93E81D2F Q33832795-C844F801-2917-4624-9996-A853044DCF06 Q33944677-EF3D7AAB-1F80-4161-832B-5FA6BEF35497 Q34059086-3CAD94BF-DC61-46D5-9B0F-AAE6F10A96AF Q34079309-F768ED4E-23A3-43D2-B8C0-6D402CADA6A7 Q34401462-497EAD93-3031-4E86-89BC-218F841F441C Q34458459-48DE3A7A-0346-469B-BD62-B842A752BA6B Q34498537-F25C507F-35A6-4914-BF47-468E28164F5A Q34658846-2DCE3FD7-7F74-458A-B8EB-0A4C98950DE5 Q34780834-FC3801FE-802E-43F9-80E6-04722766D890 Q35079198-47457FE3-2D90-4320-8545-9DD3B42EBC01 Q35322167-476CA6CB-B4F8-48D4-A199-41ADE63D563A Q35553941-6DDA86DB-0E85-41E5-A589-6E8C5E72F794 Q35590466-233D807E-8853-4F55-8D33-904B855844F7 Q35959633-A98496F8-6F93-43A7-B0E6-835B222FBA49 Q36057021-B4CA2626-7818-42D6-9FB9-C60660D70330 Q36071481-4D10CDB4-DE96-4B74-B012-E46CB67FAD81

P2860

Extended results of the Alzheimer's disease anti-inflammatory prevention trial.

http://www.wikidata.org/entity/Q35146385

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Extended results of the Alzheimer's disease anti-inflammatory prevention trial.

@ast

Extended results of the Alzheimer's disease anti-inflammatory prevention trial.

@en

type

label

Extended results of the Alzheimer's disease anti-inflammatory prevention trial.

@ast

Extended results of the Alzheimer's disease anti-inflammatory prevention trial.

@en

prefLabel

Extended results of the Alzheimer's disease anti-inflammatory prevention trial.

@ast

Extended results of the Alzheimer's disease anti-inflammatory prevention trial.

@en

P1433

Q35146385-DB1087D3-2C32-4EA9-857C-0C5D7C3F0A3E

P1476

Q35146385-4E125789-327E-49F0-87B5-DB88E8077FDA

P2093

Q35146385-04D9BC4D-0115-4C66-9B8B-D5DEA2A53388

Q35146385-05064F5F-3F0B-420B-B810-3313BEAD71DA

Q35146385-0BAA107E-9604-48EC-83F8-42DD7608E0C9

Q35146385-0DA4E968-40B6-4121-AD01-937B20FE3C86

Q35146385-1F481691-561C-435A-B98B-6C33E1755E02

Q35146385-5CC94B17-5DE7-43B2-862F-BCD8B36B438F

Q35146385-6124531E-160E-4DAC-980F-5B3E8DA6B449

Q35146385-8E31005D-E45A-48DB-85E9-F971171CD6FD

Q35146385-A0B256B9-EBBB-44C7-87EC-D52B0967BF84

Q35146385-A4DA45CA-5C9B-4EF3-BCFE-89F521A41AAD

P2860

Q35146385-112601A1-0284-4DE1-9623-CD1D05ABBB21

Q35146385-121C57C5-7C79-44E1-A0CD-AE276655167E

Q35146385-17520692-6F39-4D10-87DE-BA5B9DB79F9F

Q35146385-195A049B-0231-4AFD-B2C9-D93627D6BED7

Q35146385-2209ACB4-E0E4-4B47-9697-802A33562E49

Q35146385-22E19D67-8081-44C2-9A7E-D9D783B999F7

Q35146385-3759A3C7-5CCB-4160-876E-5224B989E47C

Q35146385-3988016A-60EC-4661-B9FE-976CD1C934ED

Q35146385-39B2A6DA-FE2F-4BE7-8ACA-7D43DEF6E7D5

Q35146385-3E397D9F-D89E-43E4-A5E8-A2266828AC09

P304

Q35146385-9CBF4E40-3A41-42D2-AB68-553AAD9D8B27

P31

Q35146385-00EDF94B-0901-4AA0-B38B-F65A8881E2DB

P356

Q35146385-75BB6A3A-2BCE-4147-967C-CC72E108D683

P433

Q35146385-A931D32D-FECB-4E5A-B845-3F5C29F79C21

P478

Q35146385-85CF817F-8EF4-4E08-9E1E-A9BDE2FB5510

P50

Q35146385-23E39006-3E21-489B-B103-B997BDF5FAFF

Q35146385-DD866510-BE74-4E32-AA29-177766D32043

P577

Q35146385-CD6DCC1F-F05D-4991-8B45-4D6384659C3B

P5875

Q35146385-29398934-1E17-4A69-BC23-86E8FE6909A5

P698

Q35146385-A6DFF189-8EF4-4598-AA09-288FC2876C28

P921

Q35146385-143B10BC-AB09-4E86-A182-76978CF1305A

Q35146385-420E6DA3-DDEF-4759-98A8-A0A049311576

P932

Q35146385-6365CC82-3045-49BB-9A1C-F2DE3EFEE1FF

P356

J.JALZ.2010.12.014

P1433

Alzheimer's and Dementia

P1476

Extended results of the Alzheimer's disease anti-inflammatory prevention trial.

@en

P2093

ADAPT Research Group

http://www.w3.org/2001/XMLSchema#string

Barbara K Martin

http://www.w3.org/2001/XMLSchema#string

Constantine G Lyketsos

http://www.w3.org/2001/XMLSchema#string

Curtis L Meinert

http://www.w3.org/2001/XMLSchema#string

Denis E Evans

http://www.w3.org/2001/XMLSchema#string

John C Breitner

http://www.w3.org/2001/XMLSchema#string

Karen H Ashe

http://www.w3.org/2001/XMLSchema#string

Laura D Baker

http://www.w3.org/2001/XMLSchema#string

M Saleem Ismail

http://www.w3.org/2001/XMLSchema#string

Marwan Sabbagh

http://www.w3.org/2001/XMLSchema#string

P2860

No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior

“Mini-mental state”

Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

Biomarkers for cognitive impairment and dementia in elderly people.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity.

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review.

The neuropathology of probable Alzheimer disease and mild cognitive impairment.

Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results

P304

402-411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JALZ.2010.12.014

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Robert C. Green

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51516669

http://www.w3.org/2001/XMLSchema#string

P698

21784351

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3149804

http://www.w3.org/2001/XMLSchema#string